Search research articles
Contact Us
Filters
Showing results (1-10 of 18) with videos related to
Page
of 2
Sort By:
Ecancermedicalscience
|
February 28, 2024
Real-world data on triple-negative breast cancer in Latin America and the Caribbean
Katsuki Arima Tiscoski, Juliana Giacomazzi, Matheus Soares Rocha, et al.
Archives of Medical Research
|
December 2, 2022
Socioeconomic Impact of Cancer in Latin America and The Caribbean
Gustavo Werutsky, Gustavo Gössling, Rodrigo Azevedo Pellegrini, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
December 29, 2020
Evaluation of dried blood spots as an alternative matrix for therapeutic drug monitoring of abiraterone and delta(4)-abiraterone in prostate cancer patients
Thaís Luise Dillenburg Weiss, Gustavo Gössling, Marina Venzon Antunes, et al.
Revista Brasileira De Ortopedia
|
December 30, 2024
Recurrent Aggressive Osteoblastoma of the Cervical Spine Successfully Treated with Radiotherapy
Gabriel Marques Dos Anjos, Marcos Antonio Freiberger Bassan, Gustavo Gössling, et al.
Biomedical Chromatography : BMC
|
July 12, 2020
A quick UPLC-MS/MS method for therapeutic drug monitoring of abiraterone and delta(4)-abiraterone in human plasma
Thaís Luise Dillenburg Weiss, Carolina Mesquita Furtado, Marina Venzon Antunes, et al.
Current Oncology (Toronto, Ont.)
|
January 20, 2023
Current Scenario of Clinical Cancer Research in Latin America and the Caribbean
Gustavo Gössling, Taiane F Rebelatto, Cynthia Villarreal-Garza, et al.
Future Oncology (London, England)
|
May 24, 2023
Results of a survey study on health professionals' perceptions of tumor boards in Brazil
Thamirys U Menezes, Márcia Mp Serra, Carlos He Barrios, et al.
Clinical Biochemistry
|
April 22, 2014
Development, validation and clinical application of a HPLC-FL method for CYP2D6 phenotyping in South Brazilian breast cancer patients
Marina Venzon Antunes, Dilana Elisabeth Staudt, Suziane Raymundo, et al.
Pharmacogenomics
|
April 21, 2015
CYP3A4*22 is related to increased plasma levels of 4-hydroxytamoxifen and partially compensates for reduced CYP2D6 activation of tamoxifen
Marina Venzon Antunes, Vanessa de Oliveira, Suziane Raymundo, et al.
Therapeutic Drug Monitoring
|
April 9, 2015
Influence of CYP2D6 and CYP3A4 Phenotypes, Drug Interactions, and Vitamin D Status on Tamoxifen Biotransformation
Marina V Antunes, Tatiana Aparecida da Fontoura Timm, Vanessa de Oliveira, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 18) with videos related to
Sort By:
Page
of 2
Ecancermedicalscience
|
February 28, 2024
Real-world data on triple-negative breast cancer in Latin America and the Caribbean
Katsuki Arima Tiscoski, Juliana Giacomazzi, Matheus Soares Rocha, et al.
Archives of Medical Research
|
December 2, 2022
Socioeconomic Impact of Cancer in Latin America and The Caribbean
Gustavo Werutsky, Gustavo Gössling, Rodrigo Azevedo Pellegrini, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
December 29, 2020
Evaluation of dried blood spots as an alternative matrix for therapeutic drug monitoring of abiraterone and delta(4)-abiraterone in prostate cancer patients
Thaís Luise Dillenburg Weiss, Gustavo Gössling, Marina Venzon Antunes, et al.
Revista Brasileira De Ortopedia
|
December 30, 2024
Recurrent Aggressive Osteoblastoma of the Cervical Spine Successfully Treated with Radiotherapy
Gabriel Marques Dos Anjos, Marcos Antonio Freiberger Bassan, Gustavo Gössling, et al.
Biomedical Chromatography : BMC
|
July 12, 2020
A quick UPLC-MS/MS method for therapeutic drug monitoring of abiraterone and delta(4)-abiraterone in human plasma
Thaís Luise Dillenburg Weiss, Carolina Mesquita Furtado, Marina Venzon Antunes, et al.
Current Oncology (Toronto, Ont.)
|
January 20, 2023
Current Scenario of Clinical Cancer Research in Latin America and the Caribbean
Gustavo Gössling, Taiane F Rebelatto, Cynthia Villarreal-Garza, et al.
Future Oncology (London, England)
|
May 24, 2023
Results of a survey study on health professionals' perceptions of tumor boards in Brazil
Thamirys U Menezes, Márcia Mp Serra, Carlos He Barrios, et al.
Clinical Biochemistry
|
April 22, 2014
Development, validation and clinical application of a HPLC-FL method for CYP2D6 phenotyping in South Brazilian breast cancer patients
Marina Venzon Antunes, Dilana Elisabeth Staudt, Suziane Raymundo, et al.
Pharmacogenomics
|
April 21, 2015
CYP3A4*22 is related to increased plasma levels of 4-hydroxytamoxifen and partially compensates for reduced CYP2D6 activation of tamoxifen
Marina Venzon Antunes, Vanessa de Oliveira, Suziane Raymundo, et al.
Therapeutic Drug Monitoring
|
April 9, 2015
Influence of CYP2D6 and CYP3A4 Phenotypes, Drug Interactions, and Vitamin D Status on Tamoxifen Biotransformation
Marina V Antunes, Tatiana Aparecida da Fontoura Timm, Vanessa de Oliveira, et al.
Page
of 2